Coffee, CBD and the 07:42: A Dispassionate Guide to Combining Two Daily Habits

There is a particular scene that recurs on British transport: a paper cup in one hand, a phone in the other, and somewhere in a rucksack a small amber bottle that will not be opened until half past nine at night. Coffee in the morning, CBD in the evening. Two habits, two very different purposes, and a great deal of unexamined assumption in between.

This article does not argue that CBD is a remedy for the stresses of the commute, nor that it should be avoided. It sets out what the evidence and the labelling actually support, so that a routine can be built on something more durable than a slogan on a bottle.

What the label is entitled to say

In the UK, cannabidiol sold as a food supplement sits within the novel foods framework. Products must appear on the Food Standards Agency's public list, and the agency's precautionary advice for healthy adults remains 70mg of CBD per day. CBD is not an authorised medicine, and no product should imply that it treats anxiety, insomnia or any other condition.

Labels should state the CBD content per serving and per container, the batch number, and the THC level. The legal expectation for reputable food supplements is that THC is not present at a detectable level; a product that advertises conspicuous THC content is not a food supplement, whatever the shelf it sits on.

Those points are unglamorous but they matter, because a routine built on an unverified product is not a routine at all — it is a guess with a flavour.

Two substances, two clocks

Caffeine and CBD behave quite differently in the body, and treating them as a matched pair is the first error to avoid.

Caffeine is absorbed quickly, reaching peak plasma concentration within roughly half an hour to two hours depending on the individual and whether food is present. Its half-life in healthy adults is commonly cited at around five hours, though smoking, pregnancy, oral contraceptives and genetic variation in the CYP1A2 enzyme can shift that considerably.

CBD, by contrast, is poorly and erratically absorbed. An oil held under the tongue for sixty to ninety seconds will typically produce effects within fifteen to forty-five minutes; a swallowed capsule may take one to two hours and deliver a substantially lower fraction of the dose. Its half-life is variable and, in repeated-dose studies, longer than after a single dose.

Put simply: coffee makes itself known quickly and leaves at a predictable pace. CBD arrives by a less reliable route.

The interaction question

A reasonable person might ask whether CBD slows the clearance of caffeine. It is a fair question, and the honest answer is that the laboratory evidence is clearer than the human evidence.

CBD is a known inhibitor of several cytochrome P450 enzymes in vitro, including CYP1A2, CYP2C19 and CYP3A4. Caffeine is metabolised chiefly by CYP1A2. On paper, therefore, a plausible mechanism exists by which a substantial dose of CBD could slow caffeine breakdown and prolong stimulation.

What is missing is robust human data at the doses typically sold in UK shops. The studies that show meaningful enzyme effects tend to involve pharmaceutical-grade CBD at far higher doses, often in patients with epilepsy. Extrapolating from those to a 20mg dropper taken after dinner is not sound reasoning, but neither is dismissing the mechanism altogether.

The practical implication is modest and sensible: if you are going to combine the two, do so deliberately and observe your own response, rather than assuming CBD will smooth the edges off a fourth espresso.

What CBD does not do

It is worth being blunt about the folklore. CBD is not a counterweight to caffeine. It does not neutralise stimulation, sober anyone up, or repair a poor night's sleep. There is no credible evidence that it accelerates caffeine metabolism or blunts its cardiovascular effects.

Nor is the evidence base for CBD and everyday anxiety as settled as retail marketing implies. A number of small trials, several of them using acute dosing in laboratory settings, have reported reduced anxiety in specific paradigms; reviews of the wider literature have consistently called for larger, better-controlled studies. The picture for sleep is weaker still.

The National Institute for Health and Care Excellence does not recommend CBD for general anxiety or insomnia outside of a licensed indication. This does not mean nothing is happening for some users; it means the effect has not been demonstrated with sufficient rigour to make a general claim.

Where format changes the routine

A routine is only as good as the product that carries it. The categories differ materially.

• Oils and drops offer flexible dosing and relatively fast onset if held sublingually. They require a steady hand and a note of the actual milligram figure, not the bottle size.
• Capsules are convenient and consistent but slower, and typically deliver less CBD per milligram than a well-absorbed oil.
• Gummies are palatable, easy to over-consume, and frequently contain sugar alongside modest CBD content.
• Vapes act quickly, but the evidence on inhaled CBD is thin and the respiratory considerations are separate from the CBD question.
• CBD-infused coffees and canned drinks merit particular scepticism. The CBD content is often low relative to the price, and the combination can obscure how much of either substance is being consumed.

A calm checklist for UK shoppers

1. Confirm the product appears on the FSA novel foods list before buying.
2. Record the milligram figure you actually take, and the time you take it.
3. Keep the two habits apart while you establish a baseline — a week of coffee as usual, then introduce CBD and observe.
4. If you notice restlessness, palpitations or disrupted sleep, suspect the combination rather than either substance alone.
5. Read the patient information leaflet of any prescription medicine you take. CBD interacts with several, including some anticoagulants and antiepileptics; ask a pharmacist.
6. Do not use CBD if you are pregnant or breastfeeding, or under eighteen.
7. Keep expectations modest and review them. If a product appears to be doing nothing after a month of consistent use, that is useful information.

When a professional should be involved

If you take prescribed medication, have a liver condition, or are being treated for a mental health difficulty, a conversation with a GP or pharmacist should precede any new supplement. The same applies if you drive for work: THC is not permitted at any level under UK drug-driving law, and the responsibility for what is in the bottle sits with the buyer.

The routine worth keeping

The commuter with the flat white and the evening dropper is not doing anything reckless. But the routine deserves better than assumption. Coffee is well characterised and reliable; CBD is neither. Treating them as a matched pair flatters the second and muddles the first.

A defensible routine is unremarkable: a verified product, a recorded dose, a consistent time, an honest note of what changes and what does not. That is less satisfying than a promise, and considerably more useful.

This article is for general information and is not medical advice. Speak to a pharmacist or GP before combining CBD with any medication.